Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04784065 · ClinicalTrials.gov registry record · NA
A Pilot Randomized Controlled Trial for Hand Osteoarthritis
A NA study of Hand Osteoarthritis, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 2
- Study locations
NCT04784065: Completed NA study of Hand Osteoarthritis, sponsored by Baylor College of Medicine.
NCT04784065 is a NA study of Hand Osteoarthritis that has completed, run by Baylor College of Medicine. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04784065, a NA study of Hand Osteoarthritis, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a study involving people receiving care at the Michael E. DeBakey VA Medical Center, Houston Texas. We are studying people who have hand osteoarthritis (the most common form of arthritis that involves the hand) and testing treatments for the condition with the hope that we can help to improve hand pain as well as limit the damage that occurs related to the arthritis. People who choose to participate, are randomly assigned to one of two treatments, both expected to be helpful.
Primary Outcome
An assessment of pain intensity in a given hand. - high values are worse outcomes. Minimum score = 0 Maximum score = 100
Conditions Studied
Interventions
- DEVICE Hand orthosis
Study Locations (2)
New York
- NYU Langone - New York
Texas
- Michael E. DeBakey VA Medical Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2021-02-11 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
What the finished NCT04784065 record still lists
NCT04784065 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Hand Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Hand orthosis is the first listed.
NCT04784065 reports a single indexed study location in New York, Texas.
Frequently Asked Questions
What is clinical trial NCT04784065 about?
NCT04784065 is a clinical study titled "A Pilot Randomized Controlled Trial for Hand Osteoarthritis". This is a study involving people receiving care at the Michael E. DeBakey VA Medical Center, Houston Texas. We are studying people who have hand osteoarthritis (the most common form of arthritis that involves the hand) and testing treatments for the condition with the hope that we can help to improv...
What is the current status of trial NCT04784065?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2021-02-11. Estimated completion is 2024-04-01.
What conditions does trial NCT04784065 study?
This clinical trial studies the following conditions: Hand Osteoarthritis.
What interventions are being tested in trial NCT04784065?
The interventions under investigation include: Hand orthosis (DEVICE).
Who is sponsoring clinical trial NCT04784065?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04784065 being conducted?
This trial has 2 study locations across New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hand Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04784065's enrollment target sits among peer trials
33 1574th of 2000 higher than 423 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI